If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
138.40    1.40 (1.02%)
Bid:
138.20
Ask:
138.60
Spread: 0.40 (0.289%)
Market Cap: £283.85m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Trading Update

15 Jan 2019 07:00

RNS Number : 0657N
Forterra plc
15 January 2019
 

15 January 2019

Forterra plc

Trading update

 

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update for the year ended 31 December 2018.

 

Trading in the final quarter of 2018 was good, underpinned by the sustained strength of the new build residential market. Based on this, full year profit before tax is anticipated to be in line with the Board's expectations.

 

Brick volumes for the year were modestly ahead of 2017, and we were able to meet demand through a double digit increase in output reflecting full year production at the Accrington and Claughton facilities, and the investment made in debottlenecking projects. This increase in output meant that brick inventory levels reduced at a lower rate than in 2017, and there was a better balance between sales and production. Overall block sales volumes were ahead of prior year, with aircrete volumes increasing as the substitution effect of aggregate blocks in 2017 was reversed. Sales of precast concrete products have continued to improve as anticipated, and the integration of the Bison Swadlincote facility has progressed well with a sustained increase in productivity during the last quarter. The kiln repair at the Desford brick plant in Leicestershire was completed before Christmas and production re-commenced.

 

The Group continues to generate a strong level of operating cashflow, helped in the last quarter by improved working capital arising mainly from collections of receipts from customers. Capital expenditure included an investment of £4.5m made in December 2018 to secure further long-term clay reserves for the London Brick facility. Net debt at 31 December 2018 was approximately £39m compared with £61m at the start of 2018.

 

The UK brick market has continued to perform well, with high levels of capacity utilisation across the industry due to the sustained increase in new housing output over the last few years. Brick imports have increased to help satisfy demand and now represent over 16% of total UK demand. The overall fundamentals of the market continue to be favourable, supported by the Government's commitment to further increase new housebuilding. In this context, the Group announced in May 2018 a project to build a new brick factory at Desford which will increase our total brick capacity by 16% whilst also reducing the cash cost of production. The application for planning consent for this project is being progressed following submission to the local authority.

 

Annual results for the financial year ended 31 December 2018 will be announced on 12 March 2019.

 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO)

Shatish Dasani (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBRGDBBSBBGCS
Date   Source Headline
30th Oct 20244:54 pmRNSHolding(s) in Company
28th Oct 202411:51 amRNSHolding(s) in Company
2nd Oct 20245:35 pmRNSGrant of Options under 2024 SAYE Scheme
11th Sep 20247:00 amRNSDirectorate Change
5th Sep 202411:49 amRNSHolding(s) in Company
2nd Sep 20249:59 amRNSHolding(s) in Company
12th Aug 20243:03 pmRNSHolding(s) in Company
30th Jul 20247:00 amRNSSix months ended 30 June 2024
14th Jun 202410:02 amRNSHolding(s) in Company
11th Jun 20244:45 pmRNSAnnual General Meeting 2024 Results - Replacement
10th Jun 202411:39 amRNSHolding(s) in Company
7th Jun 202410:50 amRNSHolding(s) in Company
6th Jun 20243:38 pmRNSDirector/PDMR Shareholding
6th Jun 20243:34 pmRNSDirector/PDMR Shareholding
31st May 20248:12 amRNSDirector/PDMR Shareholding
21st May 20244:39 pmRNSAnnual General Meeting 2024 Results
21st May 20249:00 amRNSDirector/PDMR Shareholding
21st May 20247:50 amRNSProgressive publishes new research
21st May 20247:00 amRNS2024 AGM Trading Update
14th May 202411:44 amRNSHolding(s) in Company
2nd May 202410:46 amRNSGrant under Performance Share Plan
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase
25th Apr 20237:00 amRNSNotification of Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.